| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 07/05/2000 | EP1015604A1 Human prl-1 phosphatase |
| 07/05/2000 | EP1015472A1 Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases |
| 07/05/2000 | EP1014976A1 Novel substituted imidazole compounds |
| 07/05/2000 | EP1014970A1 Parasiticidal formulations |
| 07/05/2000 | CN1259136A 4'-substituted-9-deoxo-9A-AZA-9A-homoerythromycin a derivatives |
| 07/05/2000 | CN1259135A 9-oxime erythromycin derivatives |
| 07/05/2000 | CN1259129A Desoxycyclodepsipeptides and their use for combatting endoparasites |
| 07/05/2000 | CN1259128A Thiodepsipeptides for combating endoparasites and a method for producing the same |
| 07/05/2000 | CN1258505A Animal's parasiticide emulsion containing avermectin, ivermectin or chlorocyaniosaliamine |
| 07/05/2000 | CN1054124C Aminoquinoline derivatives and its application of salt |
| 07/04/2000 | US6084120 β-Alkoxyacrylates against malaria |
| 07/04/2000 | US6083992 Use of 2-methylamino-2-phenylcyclohexanone for the treatment of bacterial infections |
| 07/04/2000 | US6083965 Antiparasitic agents |
| 06/29/2000 | WO2000037639A2 Lymphocytic membrane proteins |
| 06/29/2000 | WO2000037441A1 Melatonin derivatives and medicine containing same |
| 06/29/2000 | WO2000037101A1 Method to produce inactivated w/o emulsion adjuvated vaccines |
| 06/29/2000 | WO2000037084A1 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma |
| 06/29/2000 | WO2000037064A2 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma |
| 06/29/2000 | WO2000037063A2 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma |
| 06/29/2000 | WO2000016757A8 Use of organophosphorous compounds for producing medicaments for the therapeutic and prophylactic treatment of infections or as a fungicide, bactericide or herbicide for plants |
| 06/29/2000 | WO2000012506A3 Collections of compounds |
| 06/29/2000 | DE19854310A1 Verwendung von Phosphonoameisensäurederivaten zur therapeutischen und prophylaktischen Behandlung von Infektionen Using Phosphonoameisensäurederivaten for the therapeutic and prophylactic treatment of infections |
| 06/29/2000 | CA2356181A1 Triazineone compounds for treating diseases due to sarcocystis, neospora and toxoplasma |
| 06/29/2000 | CA2355704A1 Melatonin derivatives and medicine containing same |
| 06/29/2000 | CA2355074A1 Lymphocytic membrane proteins |
| 06/28/2000 | EP1012331A1 Compositions and methods for the delivery of oligonucleotides via the alimentary canal |
| 06/28/2000 | EP1012305A1 Component of bromelain |
| 06/28/2000 | EP1012304A1 Component of bromelain |
| 06/28/2000 | EP1012266A1 Galectin 8, 9, 10 and 10sv |
| 06/28/2000 | EP1012238A1 Peptides and peptide-loaded antigen presenting cells for the activation of ctl |
| 06/28/2000 | EP1012187A2 Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response |
| 06/28/2000 | EP1011721A1 Vaginal lactobacillus medicant |
| 06/28/2000 | EP1011698A1 Chemical supplementation of bone |
| 06/28/2000 | CN1258293A Substd. 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines and method of reducing TNF 'alpha' levels |
| 06/28/2000 | CN1258282A Parasiticidal pyrazoles |
| 06/27/2000 | US6080733 Thioureido-cyclodextrins, utilized in particular to solubilize anti-tumor, and antiparasitic agents and their preparation processes |
| 06/23/2000 | CA2256124A1 Chimeric gene formed of the dna sequences that encode the antigenic determinants of four proteins of l. infantum, and protein encoded by said gene, and pharmaceutical composition useful for preventing and/or treating leishmaniosis in animals or humans |
| 06/22/2000 | WO2000035945A1 Cyclic peptide antifungal agents having a sugar substituent |
| 06/22/2000 | WO2000035944A1 Cyclic peptide antifungal agents |
| 06/22/2000 | WO2000035884A1 Control of arthropods in animals |
| 06/22/2000 | WO2000035476A1 In ovo vaccination of 1 type marek's disease virus |
| 06/22/2000 | WO2000035452A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 06/22/2000 | WO2000035445A1 Doramectin formulations |
| 06/22/2000 | WO2000035442A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists |
| 06/22/2000 | WO2000035430A2 Homer a new target of treating psychiatric disorders |
| 06/22/2000 | WO2000035429A1 Utilization of inhibitors of the kqt1 channel in order to produce a medicament for treating diseases which are caused by parasitic helminths and ectoparasites |
| 06/22/2000 | WO1999055316A3 Kinase obtained from leishmania |
| 06/22/2000 | CA2355890A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists |
| 06/22/2000 | CA2355300A1 Utilization of inhibitors of the kqt1 channel in order to produce a medicament for treating diseases which are caused by parasitic helminths and ectoparasites |
| 06/22/2000 | CA2354323A1 Homer a new target of treating psychiatric disorders |
| 06/22/2000 | CA2354056A1 Cyclic peptide antifungal agents |
| 06/22/2000 | CA2354055A1 Cyclic peptide antifungal agents having a sugar substituent |
| 06/22/2000 | CA2347770A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 06/22/2000 | CA2320414A1 In ovo vaccination of type 1 marek's disease virus |
| 06/21/2000 | EP1009737A2 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors |
| 06/21/2000 | EP1009732A2 1-amino-alkylcyclohexane nmda receptor antagonists |
| 06/21/2000 | EP1009430A1 Vaccines |
| 06/21/2000 | DE19858253A1 Verwendung von Inhibitoren des KQt1-Kanals zur Herstellung eines Medikaments zur Behandlung von Krankheiten, die durch Helminthen und Ektoparasiten hervorgerufen werden Use of inhibitors of the KQT1 channel for preparing a medicament for the treatment of diseases which are caused by helminths and ectoparasites |
| 06/21/2000 | CN1053699C Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections |
| 06/21/2000 | CN1053657C Didepside phthaleins based internal parasite compositions, novel didepside phthaleins and preparation process thereof |
| 06/21/2000 | CN1053556C Compositions containing 13-alkyl-23-imino derivative of LL-28249 compounds and their use |
| 06/20/2000 | US6077859 Pyrazoles |
| 06/20/2000 | US6077513 Drug for treatment of bilharziasis (Schistosomiasis) |
| 06/20/2000 | CA2122598C Treatment of protozoal infection with bacitracin |
| 06/15/2000 | WO2000034483A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 06/15/2000 | WO2000033873A1 Reagent and method for detecting a cryptosporidium parvum sporozoite antigen |
| 06/15/2000 | WO2000033833A1 Palladium-substituted bacteriochlorophyll derivatives and use thereof |
| 06/15/2000 | WO2000012101A3 Use of selenium for treating patients suffering from systemic inflammatory response syndrome (sirs), and composition for implementing said treatment |
| 06/15/2000 | WO2000011023A3 Ring modified cyclic peptide analogs |
| 06/15/2000 | WO2000009500A3 Nematicidal pyrazoles |
| 06/15/2000 | WO2000009107A3 Sulfonamides of n-containing heterocyclic thioesters for vision and memory disorders |
| 06/15/2000 | WO1999045016A3 Novel prodrugs for phosphorus-containing compounds |
| 06/15/2000 | CA2746535A1 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 06/15/2000 | CA2354232A1 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 06/15/2000 | CA2353526A1 Reagent and method for detecting a cryptosporidium parvum sporozoite antigen |
| 06/14/2000 | EP1007563A1 Hm74a receptor |
| 06/14/2000 | EP1007550A2 COMPOUNDS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF $i(EHRLICHIA) INFECTION |
| 06/14/2000 | EP1007539A1 Secreted proteins and polynucleotides encoding them |
| 06/14/2000 | EP1007527A1 Optically pure camptothecin analogues, optically pure synthesis intermediate and method for preparing same |
| 06/14/2000 | EP1007516A1 Dicyclanil polymorphs and hydrates and their preparation |
| 06/14/2000 | EP1007081A1 Universal t-cell epitopes for anti-malarial vaccines |
| 06/13/2000 | US6075043 Parasiticidal pyrazoles |
| 06/13/2000 | US6074635 T cell activation |
| 06/13/2000 | CA1341027C Phosphonoalkylpurine derivatives |
| 06/08/2000 | WO2000032745A2 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 06/08/2000 | WO2000032616A1 Hygromycin a derivatives as antibacterial agents |
| 06/08/2000 | WO2000032201A2 Use of 17-ketosteroids for the treatment of malaria and trypanosomiasis |
| 06/08/2000 | WO2000009086A3 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods |
| 06/08/2000 | CA2356539A1 Use of 17-ketosteroid compounds and derivatives, metabolites and precursors thereof in the treatment of malaria and the treatment of african and american trypanosomiasis |
| 06/08/2000 | CA2352466A1 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 06/07/2000 | EP1005368A1 USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE AS AN ADJUVANT |
| 06/07/2000 | EP1005364A1 Method of protecting against chronic infections |
| 06/07/2000 | EP1005342A1 Pharmaceutical compositions of tizoxanide and nitazoxanide |
| 06/07/2000 | CN1255923A 6-substituted 1,2,4a,51,8a,8b hexahydro- and 1,2,3,4,4a,5a,8a,8b-octahydro-6h-pyrrolo [3',4': 4,5] furo [3,2-b] pyrid-8(7h)-on derivatives and their use in combatting encoparasites |
| 06/07/2000 | CN1255852A Novel method and compsns. for drug feeding of taxad alkyl compounds |
| 06/07/2000 | CN1255334A Ointment for treating face mite disease |
| 06/06/2000 | US6071948 Treatment of diseases caused by excessive blood vessel growth |
| 06/06/2000 | US6071905 Treating tuberculosis, mycobacteriosis, viral and immune diseases, chlamydia infections, antitumor and -carcinogenic agents; microbiocides, in particular to mycobacteria resistant to isoniazide; stimulantes interferons |
| 06/06/2000 | US6071518 GP900 glycoprotein and fragments for treatment and detection/diagnosis of cryptosporidium |
| 06/02/2000 | WO2000031263A2 Gtpase associated proteins |